Cognetivity Neurosciences Ltd.
CGNSF · OTC
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $21 | $33 | $34 | $9 |
| - Cash | $2 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $20 | $33 | $32 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2 | -$0 | -$0 | -$0 |
| % Margin | -4,694.9% | – | – | – |
| EBITDA | -$6 | -$13 | -$2 | -$3 |
| % Margin | -14,067.1% | – | – | – |
| Net Income | -$7 | -$13 | -$2 | -$3 |
| % Margin | -16,386.3% | – | – | – |
| EPS Diluted | -0.087 | -0.18 | -0.033 | -0.058 |
| % Growth | 51.4% | -447.1% | 43.3% | – |
| Operating Cash Flow | -$6 | -$3 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$3 | -$2 | -$2 |